Vivera Pharmaceuticals has launched LabPort, a new testing software application that aims to streamline the diagnostic testing and results reporting process.
Featuring artificial intelligence (AI)-based identity verification, LabPort aims to facilitate immediate results reporting for diagnostic testing even in high-volume, field-based testing environments. It can integrate with other laboratory information management systems so information can be shared seamlessly.
Also, the cloud-based software offers an immediate solution for companies with more than 100 employees that are mandated by the U.S. government to comply with the Occupational Safety and Health Administration's (OSHA) emergency temporary standard COVID-19 vaccine and testing reporting requirements.
